Abstract Objectives Genome-Wide Association Studies (GWAS) of Schizophrenia (SCZ)
have provided new biological insights; however, most cohorts are of European ancestry. As …

Schizophrenia is a devastating neuropsychiatric disorder with genetically complex traits.
Genetic variants should explain a considerable portion of the risk for schizophrenia, and …

Genome‐wide association studies (GWASs) have identified multiple schizophrenia (SCZ)
risk variants for samples of European and East Asian descent, but most of the identified …

Background The genetic etiology of schizophrenia (SCZ) overlaps with that of other major
psychiatric disorders in samples of European ancestry. The present study investigated …

Schizophrenia is a severe and highly heritable neuropsychiatric disorder. Recent genetic
analyses including genome-wide association studies (GWAS) have implicated multiple …

In the 1980s there was extensive debate as to whether schizophrenia exists to the same
extent in all cultures and geographic areas throughout the world (reviewed in ref. 1). While …

Genome-wide association studies (GWASs) have identified> 100 susceptibility loci for
schizophrenia (SCZ) and demonstrated that SCZ is a polygenic disorder determined by …

Schizophrenia is a highly heritable psychiatric disorder with unclear aetiology. Recent
genome-wide association studies (GWAS) in European populations have reported …

Schizophrenia is a common polygenetic disease affecting 0.5–1% of individuals across
distinct ethnic populations. PGC-II, the largest genome-wide association study investigating …

Objective The authors used a genome-wide association study (GWAS) of multiply affected
families to investigate the association of schizophrenia to common single-nucleotide …